Selkirk Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-248,250
Closed -$24.7M 22
2019
Q3
$24.7M Hold
248,250
13.91% 2
2019
Q2
$22.9M Hold
248,250
12.35% 2
2019
Q1
$23.4M Hold
248,250
13.28% 2
2018
Q4
$15.9M Sell
248,250
-21,750
-8% -$1.61M 10.77% 2
2018
Q3
$24.2M Hold
270,000
12.31% 2
2018
Q2
$21.4M Hold
270,000
11.04% 2
2018
Q1
$24.1M Buy
270,000
+10,000
+4% +$960K 12.36% 1
2017
Q4
$27.1M Buy
260,000
+11,750
+5% +$1.33M 14.49% 1
2017
Q3
$36.2M Hold
248,250
19.77% 1
2017
Q2
$32.2M Hold
248,250
18.27% 1
2017
Q1
$30.9M Hold
248,250
17.48% 1
2016
Q4
$28.7M Hold
248,250
18.26% 1
2016
Q3
$25.9M Hold
248,250
15.93% 1
2016
Q2
$24.5M Hold
248,250
14.78% 1
2016
Q1
$24.8M Sell
248,250
-11,000
-4% -$1.13M 15.53% 1
2015
Q4
$31M Hold
259,250
18.3% 1
2015
Q3
$28M Hold
259,250
17.39% 1
2015
Q2
$30M Hold
259,250
16.45% 1
2015
Q1
$29.9M Hold
259,250
16.59% 1
2014
Q4
$29M Hold
259,250
17.32% 1
2014
Q3
$24.6M Hold
259,250
15.45% 1
2014
Q2
$22.3M Hold
259,250
14.84% 1
2014
Q1
$18.1M Buy
259,250
+11,000
+4% +$871K 14.89% 1
2013
Q4
$21M Hold
248,250
15.81% 1
2013
Q3
$19.1M Hold
248,250
15.09% 1
2013
Q2
$14.5M Buy
+248,250
New +$14.9M 12.86% 1

Other funds holding CELG

Selkirk Management's CELG Position: Q4 2019 in Review

Selkirk Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 248,250 shares — an estimated $24.7M sold.

Selkirk Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $36.2M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Selkirk Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Selkirk Management sold 248,250 Celgene Corp shares in Q4 2019, an estimated $24.7M.
  • Selkirk Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Selkirk Management's Celgene Corp position peaked at $36.2M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Selkirk Management's 13F filing for Q4 2019, filed 11 Feb 2020.